Correlation Between Viridian Therapeutics and Cara Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Cara Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Cara Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Cara Therapeutic, you can compare the effects of market volatilities on Viridian Therapeutics and Cara Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Cara Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Cara Therapeutic.

Diversification Opportunities for Viridian Therapeutics and Cara Therapeutic

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viridian and Cara is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Cara Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cara Therapeutic and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Cara Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cara Therapeutic has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Cara Therapeutic go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Cara Therapeutic

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.66 times more return on investment than Cara Therapeutic. However, Viridian Therapeutics is 1.52 times less risky than Cara Therapeutic. It trades about 0.13 of its potential returns per unit of risk. Cara Therapeutic is currently generating about -0.05 per unit of risk. If you would invest  1,195  in Viridian Therapeutics on August 29, 2024 and sell it today you would earn a total of  992.00  from holding Viridian Therapeutics or generate 83.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Cara Therapeutic

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Cara Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cara Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Viridian Therapeutics and Cara Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Cara Therapeutic

The main advantage of trading using opposite Viridian Therapeutics and Cara Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Cara Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutic will offset losses from the drop in Cara Therapeutic's long position.
The idea behind Viridian Therapeutics and Cara Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bonds Directory
Find actively traded corporate debentures issued by US companies
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.